Lack of correlation between objective indicators and clinical-response scores during antimicrobial therapy for acute pulmonary exacerbations of cystic fibrosis.
Bosso
J A
JA
Department of Pharmacy Practice, College of Pharmacy, University of Utah, Salt Lake City 84112.
Walker
K B
KB
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001390:Azlocillin / Q000627:therapeutic use; D001398:Aztreonam / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D003550:Cystic Fibrosis / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D014031:Tobramycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D002939:Ciprofloxacin; D001398:Aztreonam; D001390:Azlocillin; D014031:Tobramycin